SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs > RXI Pharmaceuticals Corp (RXII)

They will have to be a reverse split

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
headshrink3 Member Profile
 
Followed By 2
Posts 94
Boards Moderated 0
Alias Born 04/24/13
160x600 placeholder
Advertisement
Prospectus Filed Pursuant to Rule 424(b)(4) (424b4) "Edgar (US Regulatory)" - 5/29/2015 4:32:41 PM
RXi Pharmaceuticals Announces $10 Million Public Offering of Common Stock and Warrants "PR Newswire (US)" - 5/28/2015 7:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/28/2015 6:10:45 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 5/28/2015 6:01:30 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 5/27/2015 5:14:03 PM
RXi Pharmaceuticals Announces Proposed Public Offering of Common Stock and Warrants "PR Newswire (US)" - 5/27/2015 4:10:00 PM
RXi Pharmaceuticals Provides an Update on Series A and Series A-1 Preferred Stock "PR Newswire (US)" - 5/27/2015 7:02:00 AM
RXi Pharmaceuticals to Present at the Jefferies 2015 Global Healthcare Conference "PR Newswire (US)" - 5/26/2015 7:02:00 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 5/22/2015 6:05:31 AM
Securities Registration Statement (s-1/a) "Edgar (US Regulatory)" - 5/21/2015 6:08:50 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/13/2015 7:13:07 AM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 5/13/2015 7:06:19 AM
RXi Pharmaceuticals Reports First Quarter 2015 Financial Results and Business Highlights "PR Newswire (US)" - 5/13/2015 7:05:00 AM
RXi Pharmaceuticals Presented Promising New Data with Self-delivering RNAi Compounds Targeting Tyrosinase and Collagenase "PR Newswire (US)" - 5/11/2015 7:02:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 5/8/2015 4:38:04 PM
RXi Pharmaceuticals Corp Rating Reiterated by Zacks (RXII) "Analyst Ratings Network" - 5/1/2015 3:05:17 PM
RXi Pharmaceuticals Corp's "Buy" Rating Reaffirmed at Zacks (RXII) "Analyst Ratings Network" - 4/30/2015 2:00:54 PM
RXi Pharmaceuticals to Webcast First Quarter 2015 Financial Results on Wednesday, May 13, 2015 "PR Newswire (US)" - 4/29/2015 7:02:00 AM
RXi Pharmaceuticals Announces Upcoming Presentations at Leading Partnering and Scientific Conferences "PR Newswire (US)" - 4/27/2015 7:02:00 AM
RXi Pharmaceuticals Receives Orphan Drug Designation for Samcyprone™ from the U.S. FDA for the Treatment of Malignant Melan... "PR Newswire (US)" - 4/17/2015 7:50:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 4/16/2015 4:34:54 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/16/2015 4:32:16 PM
Securities Registration Statement (s-1) "Edgar (US Regulatory)" - 4/13/2015 5:24:51 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/2/2015 11:16:22 AM
RXi Pharmaceuticals's (RXII) CEO Geert Cauwenbergh on Q4 2014 Results - Earnings Call Transcript "Seeking Alpha" - 3/30/2015 9:48:03 PM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist